Blood Endothelium Biomarkers to Predict Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention

NACompletedINTERVENTIONAL
Enrollment

170

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

August 31, 2010

Study Completion Date

December 31, 2010

Conditions
AtherosclerosisPercutaneous Coronary InterventionCardiovascular Diseases
Interventions
OTHER

Data private hospitals, angioplasty, sampling of blood

"* Data private hospitals : Age, sex, index of body mass, factors of cardiovascular risk, medical surgical histories, treatment before and after the angioplasty, the renal insufficiency~* coronary angioplasty~* Sampling of blood : Before the angioplasty, 6 hours after the angioplasty and 24 hours after the angioplasty. A numeration of the proparents circulants (hématopoietics, PEC) and a numeration of CEC are made"

Trial Locations (1)

13015

Service de Cardiologie- Hopital Nord, Marseille

All Listed Sponsors
lead

Assistance Publique Hopitaux De Marseille

OTHER

NCT00725868 - Blood Endothelium Biomarkers to Predict Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention | Biotech Hunter | Biotech Hunter